SAN DIEGO, July 23 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that it will report second quarter 2008 financial results on Wednesday, July 30, 2008, after the U.S. financial markets close.
Anadys will hold a conference call and webcast to discuss its second quarter 2008 financial results and highlights and to provide an update on its development programs on Wednesday, July 30, 2008 at 5:00 p.m. Eastern Daylight Time. A live webcast of the call will be available online at http://www.anadyspharma.com. A telephone replay will also be available approximately one hour after completion of the call. To access the telephone replay, dial 888-286-8010 (domestic) or 617-801-6888 (international), passcode 79911148. The webcast and telephone replay will be available through August 13, 2008.
Anadys Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to improving patient care by developing novel medicines in the areas of hepatitis C and oncology. For the treatment of chronic hepatitis C, the Company is developing ANA598, a non-nucleoside polymerase inhibitor, and ANA773, an oral TLR7 agonist prodrug. The Company is also developing ANA773 for the treatment of cancer.
Safe Harbor Statement
Statements in this press release that are not strictly historical in
nature constitute "forward-looking statements." Such statements include,
but are not limited to, references to Anadys' strategy, development
programs, and ability to develop novel medicines in the areas of hepatitis
C and oncology. Such forward-looking statements involve known and unknown
risks, uncertainties and other factors, whic
|SOURCE Anadys Pharmaceuticals, Inc.|
Copyright©2008 PR Newswire.
All rights reserved